Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
NCT03971162
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Myopic Choroidal Neovascularisation
Interventions
DRUG:
3+PRN
DRUG:
6+PRN
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University